• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Detecting SARS-CoV-2 RNA in Conjunctival Secretions: Is It a Valuable Diagnostic Method of COVID-19?

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jun 24.
doi: 10.1002/jmv.26219. Online ahead of print.
Detecting SARS-CoV-2 RNA in Conjunctival Secretions: Is It a Valuable Diagnostic Method of COVID-19?


Noemi G?emes-Villahoz[SUP] 1 [/SUP], Barbara Burgos-Blasco[SUP] 1 [/SUP], Ana Arribi Vilela[SUP] 2 [/SUP], Pedro Arriola-Villalobos[SUP] 3 [/SUP], Carla Margarita Rico Luna[SUP] 2 [/SUP], Ricardo Cui?a Sardi?a[SUP] 1 [/SUP], Alberto Delgado-Iribarren[SUP] 2 [/SUP], Juli?n Garc?a-Feijo?[SUP] 3 [/SUP]



Affiliations

Abstract

Purpose: To evaluate the presence of viral RNA of SARS-CoV-2 in conjunctival swab specimen of COVID-19 patients with and without conjunctivitis to establish the diagnostic value of reverse transcription-polymerase chain reaction (RT-PCR) in each case and to describe its clinical characteristics.
Methods: Cross-sectional study conducted at the Hospital Clinico San Carlos of Madrid, Spain. 36 subjects from the COVID admission unit with laboratory-confirmed SARS-CoV-2 infection were included. Conjunctival swabs were collected from 18 patients with conjunctivitis and 18 patients without conjunctivitis. RT-PCR was performed.
Results: Conjunctival swab was collected from both eyes of 36 patients (72 eyes), detecting SARS-CoV-2 RNA in conjunctival swab of two patients (5.5%). Among the 18 patients with conjunctivitis, only 1 of them (5.5%) showed positive results. Likewise, SARS-CoV-2 RNA was detected in 1 patient without conjunctivitis (5.5%). The mean age of the 36 patients was 67.9 years (range 28-92 years) and the male-to-female ratio was 0,44 (16:20). The mean days since onset of COVID-19 symptoms until conjunctivitis manifestation was 8 (range 1-24 days). The mean duration of the conjunctivitis was 3 days (range 1-7 days).
Conclusion: SARS-CoV-2 RNA may be detected in conjunctival swabs of both patients with and without conjunctivitis. Our study revealed the same rate of positive results amongst the group with and without conjunctivitis, suggesting that detecting SARS-CoV-2 in ocular fluids is not conditioned on the presence of conjunctivitis. The presence of SARS-CoV-2 RNA in ocular samples highlights the role of the eye as a possible route of transmission of the disease. This article is protected by copyright. All rights reserved.

Keywords: COVID; PCR; conjunctivitis; coronavirus; diagnosis.
 
Back
Top Bottom